Metabolomics reveals that CAF-derived lipids promote colorectal cancer peritoneal metastasis by enhancing membrane fluidity.
Metabolomics reveals that CAF-derived lipids promote colorectal cancer peritoneal metastasis by enhancing membrane fluidity.
复制标题
代谢组学揭示 CAF 衍生脂质通过增强膜流动性促进结直肠癌腹膜转移
DOI:
10.7150/ijbs.68484
复制
发表时间:
2022
影响因子:
9.2
通讯作者:
Liu X
中科院分区:
文献类型:
--
作者:
Peng S;Li Y;Huang M;Tang G;Xie Y;Chen D;Hu Y;Yu T;Cai J;Yuan Z;Wang H;Wang H;Luo Y;Liu X
Patients with peritoneal metastasis (PM) of colorectal cancer (CRC) have poorer overall survival outcomes than those without PM. Cancer-associated fibroblasts (CAFs) are a major component of the tumor microenvironment and mediate CRC progression and PM. It is imperative to identify and develop novel therapeutic targets for PM-CRC driven by CAFs. Using lipidomics, we reveal that the abundance of phosphatidylcholine (PC) with unsaturated acyl chains was increased in clinical PM-CRC specimens. Additionally, we found that CAFs were present at a higher relative abundance in primary PM-CRC tumors and that membrane fluidity in CRC cells was increased after incubation with CAF-conditioned medium (CM) through three independent methods: lipidomics, fluorescence recovery after photobleaching (FRAP), and generalized polarization. Then, we found that increased membrane fluidity can enhance glucose uptake and metabolism, as supported by real-time bioenergetics analysis and U-13C glucose labeling. Interestingly, stearoyl-CoA desaturase 1 (SCD), the rate-limiting enzyme in the biosynthesis of unsaturated fatty acids (uS-FAs), was expressed at low levels in PM and associated with poor prognosis in CRC patients. Importantly, by untargeted metabolomics analysis and fatty acid ([U-13C]-stearic acid) tracing analyses, we found that CRC cells take up lipids and lipid-like metabolites secreted from CAFs, which may compensate for low SCD expression. Both in vitro and in vivo experiments demonstrated that sodium palmitate (C16:0) treatment could decrease the CAF-induced change in cell membrane fluidity, limit glucose metabolism, suppress cell invasiveness, and impair tumor growth and intraperitoneal dissemination. An increased C16:0 concentration was shown to induce apoptosis linked to lipotoxicity. Furthermore, C16:0 effectively enhanced the antitumor activity of 5-fluorouracil (5-FU) in vitro and was well tolerated in vivo. Taken together, these findings suggest that adding the saturated fatty acid (S-FA) C16:0 to neoadjuvant chemotherapy may open new opportunities for treating PM-CRC in the future.
登录
查看更多内容
DOI:
10.1016/j.bbalip.2019.158540
发表时间:
2020-02-01
影响因子:
4.8
作者:
Liao, Chaoliang;Li, Min;Luo, Xiangjian
通讯作者:
Luo, Xiangjian
DOI:
10.1111/j.1440-1746.1989.tb00829.x
发表时间:
1989-05-01
影响因子:
4.1
作者:
BENEDETTI, A;FERRETTI, G;ORLANDI, F
通讯作者:
ORLANDI, F
影响因子:
13.5
作者:
Lin, Ling;Ding, Ying;Shen, Huali
通讯作者:
Shen, Huali
影响因子:
8.8
作者:
Angelucci, C.;Maulucci, G.;Colabianchi, A.;Iacopino, F.;D'Alessio, A.;Maiorana, A.;Palmieri, V.;Papi, M.;De Spirito, M.;Di Leone, A.;Masetti, R.;Sica, G.
通讯作者:
Sica, G.
影响因子:
29
作者:
Curtis M;Kenny HA;Ashcroft B;Mukherjee A;Johnson A;Zhang Y;Helou Y;Batlle R;Liu X;Gutierrez N;Gao X;Yamada SD;Lastra R;Montag A;Ahsan N;Locasale JW;Salomon AR;Nebreda AR;Lengyel E
通讯作者:
Lengyel E